Source: Heartland Daily News

As COVID-19 ‘cases’ (positive tests) surge in border states, governors are being accused of ‘re-opening too soon.’

Gov. Ducey of Arizona, Gov. Abbott of Texas, and Gov. Newsom of California are imposing more restrictions on still-surviving small businesses, and many jurisdictions are mandating mask-wearing by the public.

These measures will destroy livelihoods, but there is little evidence  they will save lives. A better, evidence-based approach would be to protect the people most at risk of exposure and infection despite protective gear. These include medical and dental workers but also law enforcement, first responders, factory workers, truck drivers, clergy, and others who serve the public.

Consider the response to HIV/AIDS. Despite decades of effort, there is no vaccine, but those who have been or might be exposed are offered post-exposure or pre-exposure prophylaxis (PEP or PrEP) with antiviral drugs. And of course, malaria prophylaxis has been routine for decades for those who live in or visit areas with high incidence of malaria.

Recently published, peer-reviewed evidence shows that the anti-malaria drug hydroxychloroquine (HCQ) is being used safely and effectively to prevent COVID-19 in exposed workers.

Policemen and others may choose to take HCQ for prophylaxis in India, but not in the U.S. Arizona Gov. Doug Ducey has explicitly prohibited prophylactic use of HCQ by executive order.  While physicians have the authority to prescribe any FDA-approved medication for any indication, most states have imposed unprecedented restrictions on physicians and pharmacists who prescribe or dispense HCQ for COVID-19.

Research at Henry Ford Health System has recently shown that HCQ cut the COVID-19 death rate in hospitalized patients by half. There are now 53 studies (33 peer-reviewed) on HCQ in COVID-19, almost all with favorable results. The very few negative studies were meaningless because the treatment was applied too late to expect a positive result.

To prevent sickness, hospitalization, death, and likely long-term health problems in COVID-19 survivors, governors must immediately remove all restrictions on HCQ use for pre- or post-exposure prophylaxis or treatment of HCQ. Doctors must be allowed to practice medicine.

Jane Orient, M.D. is executive director of the  Association of American Physicians and Surgeons (AAPS) and a policy advisor to The Heartland Institute.  


See related:

Local doctor pushing proven HCQ cocktail treatment for COVID into national debate

Brazil: Early treatment with Covid Kit including HCQ is effective and safe, says MS doctor

Oregon Pharmacy Board repeals rule that restricted use of HCQ for COVID-19 infection to patients enrolled in a clinical trial.

Irrefutable proof that hydroxychloroquine works: FranceSoir

Zelenko study: COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin; A Retrospective Case Series Study

The HIGHWIRE: ZELENKO -HCQ DENIERS ARE “GUILTY OF MASS MURDER”

Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows

How a False Hydroxychloroquine Narrative Was Created. “Dangerous” When Used for Covid-19

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Stark madness to ban ivermectin

Buried in the note is the real reason for making ivermectin inaccessible – the fear that persons taking it ‘may elect not to be vaccinated as part of the national Covid-19 vaccination program’. This is outrageous. When someone is infected with Covid, it is too late to bother with vaccination. They need early treatment. To deny it to coerce them into accepting a vaccine, one of whose side-effects is death, is immoral.

Read More »

Australia’s TGA Bans GPs from Prescribing Ivermectin

Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.

Read More »